Mark Hillman - Hillman Capital Management
Holding/activity history for GSK plc (GSK)
← All GSK superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 97,432 | 3.73 | Reduce 14.78% | 0.52 | $49.39–59.57 · VW $53.17i | $5,377,272 | SEC |
| 2025 Q4 | 114,336 | 3.53 | Reduce 19.36% | 0.69 | $47.13–61.70 · VW $55.99i | $5,607,037 | SEC |
| 2025 Q3 | 141,779 | 3.56 | Reduce 7.09% | 0.23 | $38.63–48.69 · VW $45.06i | $6,119,182 | SEC |
| 2025 Q2 | 152,599 | 3.20 | Reduce 7.60% | 0.24 | $35.45–42.63 · VW $39.25i | $5,859,802 | SEC |
| 2025 Q1 | 165,143 | 3.15 | Reduce 28.56% | 0.83 | $32.38–41.17 · VW $38.19i | $6,397,640 | SEC |
| 2024 Q4 | 231,151 | 2.90 | Add 17.40% | 0.43 | $31.72–38.40 · VW $35.90i | $7,817,527 | SEC |
| 2024 Q3 | 196,896 | 2.76 | Add 0.91% | 0.02 | $32.83–44.26 · VW $37.07i | $8,049,108 | SEC |
| 2024 Q2 | 195,126 | 2.65 | Reduce 16.43% | 0.53 | $37.81–44.67 · VW $42.13i | $7,512,336 | SEC |
| 2024 Q1 | 233,486 | 3.22 | Add 0.04% | <0.01 | $39.16–45.93 · VW $43.29i | $10,009,545 | SEC |
| 2023 Q4 | 233,386 | 2.99 | Add 0.22% | <0.01 | $35.81–42.69 · VW $40.13i | $8,649,285 | SEC |
| 2023 Q3 | 232,864 | 3.25 | Reduce 0.77% | 0.02 | $33.67–38.21 · VW $35.96i | $8,441,320 | SEC |
| 2023 Q2 | 234,681 | 2.95 | Reduce 1.15% | 0.04 | $33.33–36.57 · VW $35.01i | $8,364,031 | SEC |
| 2023 Q1 | 237,416 | 3.20 | Reduce 0.19% | <0.01 | $33.20–38.32 · VW $35.04i | $8,447,261 | SEC |
| 2022 Q4 | 237,879 | 3.28 | Reduce 2.50% | 0.07 | $34.23–39.74 · VW $36.08i | $8,359,068 | SEC |
| 2022 Q3 | 243,978 | 2.98 | Buy | 2.98 | $28.47–34.62 · VW $32.56i | $7,181,000 | SEC |
Price snapshot:
Current price$52.29
Avg. buy price$30.19
+/- since buy73.22%
52-week low$34.17
52-week high$60.65